Global Antibody Engineering Services
Global Antibody Engineering Services

Antibody Engineering Services Comprehensive Study by Application (Research, Diagnostic, Therapeutics, Others), Services (Antibody cDNA Sequencing and Cloning, Humanization, Gene Synthesis, Transient Expression, Isotype Switching, Chimerisation, Others), Antibodies (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Recombinant Antibodies) Players and Region - Global Market Outlook to 2026

Antibody Engineering Services Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Nov 2021 Edition 205 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Key Players of Antibody Engineering Services Market Study:
Promab Biotechnologies (United States), Creative Biolabs, Inc. (United States), Biologics International Corp (United States), Innovagen AB (Sweden), Abzena Ltd (United Kingdom), YUMAB (Germany), Absolute Antibody (United Kingdom), Fusion Antibodies (United Kingdom), Genscript Biotech (United States), ExonBIO (United States), LakePharma (United States), Amgen Inc. (United States), Sino Biological (China), GenScrip (United States) and WuXi Biologics (China)

In the last few years, Global market of Antibody Engineering Services developed rapidly. Major factors driving the market are Growing Cancer and Autoimmune Diseases in People .

On the basis of applications, the Antibody Engineering Services market is segmented by Research, Diagnostic, Therapeutics and Others.

Latest Industry Highlights:
On 2nd April 2020, Adaptive Extends Immune Medicine Platform to Discover Therapeutic Antibodies From Recovered COVID-19 Patients and Amgen Will Leverage Genetics, Immunology, Antibody Engineering, and Manufacturing Capabilities Companies Will Begin Work Immediately. The mutually exclusive collaboration brings together Adaptive's proprietary immune medicine platform for the identification of virus-neutralizing antibodies with Amgen's expertise in immunology and novel antibody therapy development. Given the rapidly rising incidence of COVID-19 around the world, the companies will begin work immediately and finalize financial details and terms in the coming weeks..

.

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Antibody Engineering Services market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Antibody Engineering Services market.
Identification of total players or companies operating in the global market which is further concentrated to a fewer or most impacting players which is considered under the report’s scope. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Antibody Engineering Services Providers, Antibody Engineering Services Industry Associations, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others.

This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What trending factors would impact Antibody Engineering Services Market growth most?
"Rising Drug Discovery Activities By Many Healthcare and Research Institutes " is seen as one of major influencing trends for Antibody Engineering Services Market during projected period 2020-2026.

2. Is Antibody Engineering Services Market Concentarted or Fragmented?
The Concentration Rate of Global Antibody Engineering Services market is highlighted using HHI Index.

3. Who will contribute highest growth to Antibody Engineering Services Market?
Players will contribute the maximum growth of Global Antibody Engineering Services market throughout the predicted period.
Report Objectives / Segmentation Covered
By Application
  • Research
  • Diagnostic
  • Therapeutics
  • Others
By Services
  • Antibody cDNA Sequencing and Cloning
  • Humanization
  • Gene Synthesis
  • Transient Expression
  • Isotype Switching
  • Chimerisation
  • Others

By Antibodies
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Bispecific Antibodies
  • Recombinant Antibodies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Cancer and Autoimmune Diseases in People
      • 3.2.2. Need for Diagnostics and Therapeutic Solutions for Chronic Disease
    • 3.3. Market Challenges
      • 3.3.1. Stiff Competition in the Antibody Engineering Services Market
    • 3.4. Market Trends
      • 3.4.1. Rising Drug Discovery Activities By Many Healthcare and Research Institutes
      • 3.4.2. Advancement in Biotechnology Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antibody Engineering Services, by Application, Services, Antibodies and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Antibody Engineering Services (Value)
      • 5.2.1. Global Antibody Engineering Services by: Application (Value)
        • 5.2.1.1. Research
        • 5.2.1.2. Diagnostic
        • 5.2.1.3. Therapeutics
        • 5.2.1.4. Others
      • 5.2.2. Global Antibody Engineering Services by: Services (Value)
        • 5.2.2.1. Antibody cDNA Sequencing and Cloning
        • 5.2.2.2. Humanization
        • 5.2.2.3. Gene Synthesis
        • 5.2.2.4. Transient Expression
        • 5.2.2.5. Isotype Switching
        • 5.2.2.6. Chimerisation
        • 5.2.2.7. Others
      • 5.2.3. Global Antibody Engineering Services by: Antibodies (Value)
        • 5.2.3.1. Monoclonal Antibodies
        • 5.2.3.2. Polyclonal Antibodies
        • 5.2.3.3. Bispecific Antibodies
        • 5.2.3.4. Recombinant Antibodies
      • 5.2.4. Global Antibody Engineering Services Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Antibody Engineering Services (Price)
  • 6. Antibody Engineering Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Promab Biotechnologies (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Creative Biolabs, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biologics International Corp (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Innovagen AB (Sweden)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abzena Ltd (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. YUMAB (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Absolute Antibody (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fusion Antibodies (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Genscript Biotech (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ExonBIO (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. LakePharma (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Amgen Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Sino Biological (China)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. GenScrip (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. WuXi Biologics (China)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Antibody Engineering Services Sale, by Application, Services, Antibodies and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Antibody Engineering Services (Value)
      • 7.2.1. Global Antibody Engineering Services by: Application (Value)
        • 7.2.1.1. Research
        • 7.2.1.2. Diagnostic
        • 7.2.1.3. Therapeutics
        • 7.2.1.4. Others
      • 7.2.2. Global Antibody Engineering Services by: Services (Value)
        • 7.2.2.1. Antibody cDNA Sequencing and Cloning
        • 7.2.2.2. Humanization
        • 7.2.2.3. Gene Synthesis
        • 7.2.2.4. Transient Expression
        • 7.2.2.5. Isotype Switching
        • 7.2.2.6. Chimerisation
        • 7.2.2.7. Others
      • 7.2.3. Global Antibody Engineering Services by: Antibodies (Value)
        • 7.2.3.1. Monoclonal Antibodies
        • 7.2.3.2. Polyclonal Antibodies
        • 7.2.3.3. Bispecific Antibodies
        • 7.2.3.4. Recombinant Antibodies
      • 7.2.4. Global Antibody Engineering Services Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Antibody Engineering Services (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antibody Engineering Services: by Application(USD Million)
  • Table 2. Antibody Engineering Services Research , by Region USD Million (2015-2020)
  • Table 3. Antibody Engineering Services Diagnostic , by Region USD Million (2015-2020)
  • Table 4. Antibody Engineering Services Therapeutics , by Region USD Million (2015-2020)
  • Table 5. Antibody Engineering Services Others , by Region USD Million (2015-2020)
  • Table 6. Antibody Engineering Services: by Services(USD Million)
  • Table 7. Antibody Engineering Services Antibody cDNA Sequencing and Cloning , by Region USD Million (2015-2020)
  • Table 8. Antibody Engineering Services Humanization , by Region USD Million (2015-2020)
  • Table 9. Antibody Engineering Services Gene Synthesis , by Region USD Million (2015-2020)
  • Table 10. Antibody Engineering Services Transient Expression , by Region USD Million (2015-2020)
  • Table 11. Antibody Engineering Services Isotype Switching , by Region USD Million (2015-2020)
  • Table 12. Antibody Engineering Services Chimerisation , by Region USD Million (2015-2020)
  • Table 13. Antibody Engineering Services Others , by Region USD Million (2015-2020)
  • Table 14. Antibody Engineering Services: by Antibodies(USD Million)
  • Table 15. Antibody Engineering Services Monoclonal Antibodies , by Region USD Million (2015-2020)
  • Table 16. Antibody Engineering Services Polyclonal Antibodies , by Region USD Million (2015-2020)
  • Table 17. Antibody Engineering Services Bispecific Antibodies , by Region USD Million (2015-2020)
  • Table 18. Antibody Engineering Services Recombinant Antibodies , by Region USD Million (2015-2020)
  • Table 19. South America Antibody Engineering Services, by Country USD Million (2015-2020)
  • Table 20. South America Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 21. South America Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 22. South America Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 23. Brazil Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 24. Brazil Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 25. Brazil Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 26. Argentina Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 27. Argentina Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 28. Argentina Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 29. Rest of South America Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 30. Rest of South America Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 31. Rest of South America Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 32. Asia Pacific Antibody Engineering Services, by Country USD Million (2015-2020)
  • Table 33. Asia Pacific Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 34. Asia Pacific Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 35. Asia Pacific Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 36. China Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 37. China Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 38. China Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 39. Japan Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 40. Japan Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 41. Japan Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 42. India Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 43. India Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 44. India Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 45. South Korea Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 46. South Korea Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 47. South Korea Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 48. Taiwan Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 49. Taiwan Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 50. Taiwan Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 51. Australia Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 52. Australia Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 53. Australia Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 57. Europe Antibody Engineering Services, by Country USD Million (2015-2020)
  • Table 58. Europe Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 59. Europe Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 60. Europe Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 61. Germany Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 62. Germany Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 63. Germany Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 64. France Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 65. France Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 66. France Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 67. Italy Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 68. Italy Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 69. Italy Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 70. United Kingdom Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 71. United Kingdom Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 72. United Kingdom Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 73. Netherlands Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 74. Netherlands Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 75. Netherlands Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 76. Rest of Europe Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 77. Rest of Europe Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 78. Rest of Europe Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 79. MEA Antibody Engineering Services, by Country USD Million (2015-2020)
  • Table 80. MEA Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 81. MEA Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 82. MEA Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 83. Middle East Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 84. Middle East Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 85. Middle East Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 86. Africa Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 87. Africa Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 88. Africa Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 89. North America Antibody Engineering Services, by Country USD Million (2015-2020)
  • Table 90. North America Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 91. North America Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 92. North America Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 93. United States Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 94. United States Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 95. United States Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 96. Canada Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 97. Canada Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 98. Canada Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 99. Mexico Antibody Engineering Services, by Application USD Million (2015-2020)
  • Table 100. Mexico Antibody Engineering Services, by Services USD Million (2015-2020)
  • Table 101. Mexico Antibody Engineering Services, by Antibodies USD Million (2015-2020)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Antibody Engineering Services: by Application(USD Million)
  • Table 118. Antibody Engineering Services Research , by Region USD Million (2021-2026)
  • Table 119. Antibody Engineering Services Diagnostic , by Region USD Million (2021-2026)
  • Table 120. Antibody Engineering Services Therapeutics , by Region USD Million (2021-2026)
  • Table 121. Antibody Engineering Services Others , by Region USD Million (2021-2026)
  • Table 122. Antibody Engineering Services: by Services(USD Million)
  • Table 123. Antibody Engineering Services Antibody cDNA Sequencing and Cloning , by Region USD Million (2021-2026)
  • Table 124. Antibody Engineering Services Humanization , by Region USD Million (2021-2026)
  • Table 125. Antibody Engineering Services Gene Synthesis , by Region USD Million (2021-2026)
  • Table 126. Antibody Engineering Services Transient Expression , by Region USD Million (2021-2026)
  • Table 127. Antibody Engineering Services Isotype Switching , by Region USD Million (2021-2026)
  • Table 128. Antibody Engineering Services Chimerisation , by Region USD Million (2021-2026)
  • Table 129. Antibody Engineering Services Others , by Region USD Million (2021-2026)
  • Table 130. Antibody Engineering Services: by Antibodies(USD Million)
  • Table 131. Antibody Engineering Services Monoclonal Antibodies , by Region USD Million (2021-2026)
  • Table 132. Antibody Engineering Services Polyclonal Antibodies , by Region USD Million (2021-2026)
  • Table 133. Antibody Engineering Services Bispecific Antibodies , by Region USD Million (2021-2026)
  • Table 134. Antibody Engineering Services Recombinant Antibodies , by Region USD Million (2021-2026)
  • Table 135. South America Antibody Engineering Services, by Country USD Million (2021-2026)
  • Table 136. South America Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 137. South America Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 138. South America Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 139. Brazil Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 140. Brazil Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 141. Brazil Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 142. Argentina Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 143. Argentina Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 144. Argentina Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 145. Rest of South America Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 146. Rest of South America Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 147. Rest of South America Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 148. Asia Pacific Antibody Engineering Services, by Country USD Million (2021-2026)
  • Table 149. Asia Pacific Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 150. Asia Pacific Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 151. Asia Pacific Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 152. China Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 153. China Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 154. China Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 155. Japan Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 156. Japan Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 157. Japan Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 158. India Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 159. India Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 160. India Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 161. South Korea Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 162. South Korea Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 163. South Korea Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 164. Taiwan Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 165. Taiwan Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 166. Taiwan Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 167. Australia Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 168. Australia Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 169. Australia Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 170. Rest of Asia-Pacific Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 171. Rest of Asia-Pacific Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 172. Rest of Asia-Pacific Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 173. Europe Antibody Engineering Services, by Country USD Million (2021-2026)
  • Table 174. Europe Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 175. Europe Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 176. Europe Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 177. Germany Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 178. Germany Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 179. Germany Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 180. France Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 181. France Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 182. France Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 183. Italy Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 184. Italy Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 185. Italy Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 186. United Kingdom Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 187. United Kingdom Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 188. United Kingdom Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 189. Netherlands Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 190. Netherlands Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 191. Netherlands Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 192. Rest of Europe Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 193. Rest of Europe Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 194. Rest of Europe Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 195. MEA Antibody Engineering Services, by Country USD Million (2021-2026)
  • Table 196. MEA Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 197. MEA Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 198. MEA Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 199. Middle East Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 200. Middle East Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 201. Middle East Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 202. Africa Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 203. Africa Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 204. Africa Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 205. North America Antibody Engineering Services, by Country USD Million (2021-2026)
  • Table 206. North America Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 207. North America Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 208. North America Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 209. United States Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 210. United States Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 211. United States Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 212. Canada Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 213. Canada Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 214. Canada Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 215. Mexico Antibody Engineering Services, by Application USD Million (2021-2026)
  • Table 216. Mexico Antibody Engineering Services, by Services USD Million (2021-2026)
  • Table 217. Mexico Antibody Engineering Services, by Antibodies USD Million (2021-2026)
  • Table 218. Research Programs/Design for This Report
  • Table 219. Key Data Information from Secondary Sources
  • Table 220. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antibody Engineering Services: by Application USD Million (2015-2020)
  • Figure 5. Global Antibody Engineering Services: by Services USD Million (2015-2020)
  • Figure 6. Global Antibody Engineering Services: by Antibodies USD Million (2015-2020)
  • Figure 7. South America Antibody Engineering Services Share (%), by Country
  • Figure 8. Asia Pacific Antibody Engineering Services Share (%), by Country
  • Figure 9. Europe Antibody Engineering Services Share (%), by Country
  • Figure 10. MEA Antibody Engineering Services Share (%), by Country
  • Figure 11. North America Antibody Engineering Services Share (%), by Country
  • Figure 12. Global Antibody Engineering Services share by Players 2020 (%)
  • Figure 13. Global Antibody Engineering Services share by Players (Top 3) 2020(%)
  • Figure 14. Global Antibody Engineering Services share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Promab Biotechnologies (United States) Revenue, Net Income and Gross profit
  • Figure 17. Promab Biotechnologies (United States) Revenue: by Geography 2020
  • Figure 18. Creative Biolabs, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Creative Biolabs, Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Biologics International Corp (United States) Revenue, Net Income and Gross profit
  • Figure 21. Biologics International Corp (United States) Revenue: by Geography 2020
  • Figure 22. Innovagen AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 23. Innovagen AB (Sweden) Revenue: by Geography 2020
  • Figure 24. Abzena Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Abzena Ltd (United Kingdom) Revenue: by Geography 2020
  • Figure 26. YUMAB (Germany) Revenue, Net Income and Gross profit
  • Figure 27. YUMAB (Germany) Revenue: by Geography 2020
  • Figure 28. Absolute Antibody (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Absolute Antibody (United Kingdom) Revenue: by Geography 2020
  • Figure 30. Fusion Antibodies (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Fusion Antibodies (United Kingdom) Revenue: by Geography 2020
  • Figure 32. Genscript Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 33. Genscript Biotech (United States) Revenue: by Geography 2020
  • Figure 34. ExonBIO (United States) Revenue, Net Income and Gross profit
  • Figure 35. ExonBIO (United States) Revenue: by Geography 2020
  • Figure 36. LakePharma (United States) Revenue, Net Income and Gross profit
  • Figure 37. LakePharma (United States) Revenue: by Geography 2020
  • Figure 38. Amgen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Amgen Inc. (United States) Revenue: by Geography 2020
  • Figure 40. Sino Biological (China) Revenue, Net Income and Gross profit
  • Figure 41. Sino Biological (China) Revenue: by Geography 2020
  • Figure 42. GenScrip (United States) Revenue, Net Income and Gross profit
  • Figure 43. GenScrip (United States) Revenue: by Geography 2020
  • Figure 44. WuXi Biologics (China) Revenue, Net Income and Gross profit
  • Figure 45. WuXi Biologics (China) Revenue: by Geography 2020
  • Figure 46. Global Antibody Engineering Services: by Application USD Million (2021-2026)
  • Figure 47. Global Antibody Engineering Services: by Services USD Million (2021-2026)
  • Figure 48. Global Antibody Engineering Services: by Antibodies USD Million (2021-2026)
  • Figure 49. South America Antibody Engineering Services Share (%), by Country
  • Figure 50. Asia Pacific Antibody Engineering Services Share (%), by Country
  • Figure 51. Europe Antibody Engineering Services Share (%), by Country
  • Figure 52. MEA Antibody Engineering Services Share (%), by Country
  • Figure 53. North America Antibody Engineering Services Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Promab Biotechnologies (United States)
  • Creative Biolabs, Inc. (United States)
  • Biologics International Corp (United States)
  • Innovagen AB (Sweden)
  • Abzena Ltd (United Kingdom)
  • YUMAB (Germany)
  • Absolute Antibody (United Kingdom)
  • Fusion Antibodies (United Kingdom)
  • Genscript Biotech (United States)
  • ExonBIO (United States)
  • LakePharma (United States)
  • Amgen Inc. (United States)
  • Sino Biological (China)
  • GenScrip (United States)
  • WuXi Biologics (China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation